24/7 Coverage of Breaking News and Live Events.

Return to Live Coverage

Drug's performance offers new hope in Alzheimer's battle

Newly released findings on Lecanemab show it slowed the rate of cognitive decline by 27% in patients in the early stages of the disease.

November 30, 2022

Examined